1. Home
  2. ADAM vs BIOA Comparison

ADAM vs BIOA Comparison

Compare ADAM & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ADAM

Adamas Trust Inc.

HOLD

Current Price

$10.14

Market Cap

826.7M

Sector

Technology

ML Signal

HOLD

Logo BioAge Labs Inc.

BIOA

BioAge Labs Inc.

HOLD

Current Price

$10.42

Market Cap

967.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADAM
BIOA
Founded
2003
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
826.7M
967.7M
IPO Year
2003
2024

Fundamental Metrics

Financial Performance
Metric
ADAM
BIOA
Price
$10.14
$10.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$9.17
$51.50
AVG Volume (30 Days)
885.3K
1.3M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
11.87%
N/A
EPS Growth
196.49
66.21
EPS
0.87
N/A
Revenue
N/A
$8,995,000.00
Revenue This Year
N/A
$720.93
Revenue Next Year
$5.08
N/A
P/E Ratio
$11.68
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.45
$4.38
52 Week High
$10.36
$25.96

Technical Indicators

Market Signals
Indicator
ADAM
BIOA
Relative Strength Index (RSI) 72.70 30.89
Support Level $8.61 $7.95
Resistance Level N/A $13.78
Average True Range (ATR) 0.27 1.34
MACD 0.13 -0.67
Stochastic Oscillator 88.84 11.10

Price Performance

Historical Comparison
ADAM
BIOA

About ADAM Adamas Trust Inc.

Adamas Trust Inc is an internally-managed REIT for U.S. federal income tax purposes, in the business of acquiring, investing in, financing, and managing mainly mortgage-related single-family and multi-family residential assets. Its objective is to deliver long-term stable distributions to its stockholders over changing economic conditions through a combination of net interest spread and capital gains from a diversified investment portfolio. The company's investment portfolio includes credit-sensitive single-family and multi-family assets.

About BIOA BioAge Labs Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

Share on Social Networks: